Symbollon Receives Guidance from Canadian Regulatory Authorities FRAMINGHAM, Mass., Nov. 16, 2004 (PRIMEZONE) -- Symbollon Pharmaceuticals, Inc. (OTCBB:SYMBA) today provided an update on its efforts to seek regulatory approval for IoGen(tm) in Canada. Symbollon...

Symbollon Pharmaceuticals Announces Third Quarter 2004 Results FRAMINGHAM, Mass., Nov. 12, 2004 (PRIMEZONE) -- Symbollon Pharmaceuticals, Inc. (OTCBB:SYMBA) today announced its operating results for the quarter ended September 30, 2004. For the three months...

Symbollon Pharmaceuticals Announces Completion of Private Placement to Accredited Investors FRAMINGHAM, Mass., Nov. 8, 2004 (PRIMEZONE) -- Symbollon Pharmaceuticals, Inc. (OTCBB:SYMBA) today announced the completion of a private placement to accredited investors for an aggregate of...